MetaCap

Ernexa Therapeutics Inc. Company Profile

NASDAQ: ERNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.36-0.27 (-16.56%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ernexa Therapeutics at a glance

Ernexa Therapeutics Inc. (NASDAQ: ERNA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Cambridge, MA. Ernexa Therapeutics is led by Mr. Sanjeev Luther and employs about 5 people. At a market capitalization of $2.3 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0000748592, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Ernexa Therapeutics do?

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Ernexa Therapeutics Inc.
Ticker
NASDAQ: ERNA
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Sanjeev Luther
Employees
5
Headquarters
1035 Cambridge Street, Cambridge, MA, United States
Phone
617 798 6700
SEC CIK
0000748592
Latest annual report
10-K · Mar 13, 2026

Companies similar to Ernexa Therapeutics

ERNA peer companies
CompanyPrice% ChgMarket capCompare
HCWBHCW Biologics Inc.0.7491+1.90%$2.35Mvs ERNA
ONCOOnconetix Inc.2.89-8.54%$2.37Mvs ERNA
LABTLakewood-Amedex Biotherapeutics Inc.0.2449+15.03%$2.19Mvs ERNA
GRIGRI Bio Inc.1.120.00%$2.45Mvs ERNA
RDHLRedhill Biopharma Ltd. ADR0.281-13.08%$2.50Mvs ERNA
SXTP60 Degrees Pharmaceuticals Inc.0.4682-6.36%$2.10Mvs ERNA
DRMADermata Therapeutics Inc.0.5095-4.23%$2.51Mvs ERNA
KAPAKairos Pharma Ltd.0.4359-4.62%$2.04Mvs ERNA

Related